Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s)

Details for Australian Patent Application No. 2005234666 (hide)

Owner Schering Corporation

Inventors Davis, Harry R

Agent Griffith Hack

Pub. Number AU-B-2005234666

Parent 2002335770

Filing date 18 November 2005

Wipo publication date 8 December 2005

Acceptance publication date 21 September 2006

International Classifications

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

C07D 205/08 (2006.01) Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom

Event Publications

1 December 2005 Complete Application Filed

8 December 2005 Application Open to Public Inspection

  Published as AU-B-2005234666

21 September 2006 Application Accepted

  Published as AU-B-2005234666

25 January 2007 Standard Patent Sealed

11 October 2012 Application for Amendment

  The nature of the amendment is: Amend the Patentee to read Merck Sharp & Dohme Corp. . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005234667-Electrode, photoelectric conversion element, and dye-sensitized solar cell

2005234665-Braze end isolation layer for generator armature winding bar and method for applying the isolation layer